Lewin Group, Falls Church, Virginia, USA.
Health Aff (Millwood). 2010 Feb;29(2):297-303. doi: 10.1377/hlthaff.2009.0155. Epub 2010 Jan 14.
New research provides revised comprehensive estimates that suggest that the U.S. national economic burden of pre-diabetes and diabetes reached $218 billion in 2007. This estimate includes $153 billion in higher medical costs and $65 billion in reduced productivity. The average annual cost per case is $2,864 for undiagnosed diabetes, $9,975 for diagnosed diabetes ($9,677 for type 2 and $14,856 for type 1), and $443 for pre-diabetes (medical costs only). For each American, regardless of diabetes status, this burden represents a cost of approximately $700 annually. These results underscore the urgency of better understanding how prevention and treatment strategies may or may not help reduce costs.
新的研究提供了经过修订的综合估计，表明美国 2007 年糖尿病前期和糖尿病的国家经济负担达到 2180 亿美元。这一估计包括医疗费用增加 1530 亿美元和生产力下降 650 亿美元。未确诊糖尿病的平均年度病例成本为 2864 美元，确诊糖尿病为 9975 美元（2 型糖尿病为 9677 美元，1 型糖尿病为 14856 美元），糖尿病前期为 443 美元（仅医疗费用）。对于每个美国人来说，无论其糖尿病状况如何，这一负担代表每年约 700 美元的成本。这些结果突显出，迫切需要更好地了解预防和治疗策略是否有助于降低成本。
